Intellectual Property India Publishes Patent Application for 'Anti-Cd28 Compositions' Filed by Xencor, Inc.

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517098929 A) filed by Xencor, Inc., Pasadena, U.S.A., on Oct. 14, for 'anti-cd28 compositions.'

Inventor(s) include Moore, Gregory; Davra, Viralkumar, Rameshkumer; Nam, Dong, Hyun; Gusti Zeng, Veronica; Hedvat, Michael; Qi, Jing; Rashid, Rumana; Arpp, Patrick; Delgado, Ernesto; Tan, Chaofang; Bakhit, Charles, G.; Diaz, Juan; and Preciado Jimenez, Heather.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are novel anti-CD28 x anti-STEAPl and anti-CD28 x anti-CEACAM5 antibodies and methods of using such antibodies for the treatment of related cancers."

The patent application was internationally filed on Mar. 14, 2024, under International application No.PCT/US2024/020035.

Disclaimer: Curated by HT Syndication.